Exane Derivatives Portfolio Holdings

Exane Derivatives

  • $157 Million
  • Q2 2022

Exane Derivatives has filed its 13F form on July 12, 2022 for Q2 2022 where it was disclosed a total value porftolio of $157 Million distributed in 758 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spdr S&P 500 ETF Trust with a value of $8.79M, Microsoft Corp with a value of $6.17M, Merck & Co., Inc. with a value of $5.92M, Cameco Corp with a value of $5.21M, and Ishares Inc Msci Global Select with a value of $3.52M.

Examining the 13F form we can see an decrease of $167M in the current position value, from $323M to 157M. Also it can be appreciated an additional of 57 stocks purchases and 316 closed positions.

Below you can find more details about Exane Derivatives portfolio as well as his latest detailed transactions.

Portfolio value $157 Million
ETFs: $28.2 Million
Technology: $25.8 Million
Healthcare: $20.9 Million
Energy: $19.3 Million
Industrials: $11.4 Million
Consumer Defensive: $10.7 Million
Financial Services: $10.4 Million
Consumer Cyclical: $10.2 Million
Other: $19.7 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.17T
$6.17 Million 3.94% of portfolio
24,041
Q2 2022 Reduced 14.21%
$249B
$5.92 Million 3.78% of portfolio
64,879
Q2 2022 Reduced 4.44%
$22.2B
$5.21 Million 3.33% of portfolio
247,958
Q2 2022 Added 5.23%
$268B
$3.4 Million 2.17% of portfolio
54,039
Q2 2022 Reduced 3.67%
$136B
$2.33 Million 1.49% of portfolio
50,565
Q2 2022 Added 25.56%
$197B
$2.29 Million 1.46% of portfolio
16,200
Q2 2022 Reduced 25.05%
$3.2B
$2.28 Million 1.45% of portfolio
633,789
Q2 2022 Added 26.25%
$27.8B
$2.24 Million 1.43% of portfolio
43,346
Q2 2022 Added 86.03%
$280B
$2.15 Million 1.37% of portfolio
14,857
Q2 2022 Reduced 20.69%
$167B
$1.92 Million 1.23% of portfolio
7,581
Q2 2022 Reduced 11.47%
$375B
$1.88 Million 1.2% of portfolio
10,612
Q2 2022 Added 87.92%
$213B
$1.85 Million 1.18% of portfolio
7,508
Q2 2022 Reduced 15.33%
$81.4B
$1.79 Million 1.14% of portfolio
47,794
Q2 2022 Added 67.25%
$128B
$1.61 Million 1.03% of portfolio
43,067
Q2 2022 Reduced 6.23%
$408B
$1.59 Million 1.02% of portfolio
3,325
Q2 2022 Reduced 14.85%
$202B
$1.6 Million 1.02% of portfolio
16,945
Q2 2022 Reduced 15.11%
$702B
$1.43 Million 0.91% of portfolio
12,673
Q2 2022 Reduced 11.86%
$1.51B
$1.4 Million 0.89% of portfolio
1,442,058
Q2 2022 Added 29.34%
$1.35T
$1.37 Million 0.88% of portfolio
8,517
Q2 2022 Added 20.01%
$119B
$1.32 Million 0.84% of portfolio
17,094
Q2 2022 Added 57.8%
$805M
$1.31 Million 0.84% of portfolio
267,490
Q2 2022 Added 34.26%
$336B
$1.28 Million 0.82% of portfolio
7,751
Q2 2022 Reduced 16.0%
$277B
$1.2 Million 0.77% of portfolio
2,521
Q2 2022 Reduced 25.87%
$28.6B
$1.17 Million 0.75% of portfolio
9,666
Q2 2022 Added 7.15%
$12.1B
$1.15 Million 0.73% of portfolio
40,280
Q2 2022 Added 0.68%
$53.5B
$1.06 Million 0.68% of portfolio
16,526
Q2 2022 Added 143.85%
$223B
$1.07 Million 0.68% of portfolio
9,429
Q2 2022 Reduced 10.29%
$13.2B
$1.04 Million 0.67% of portfolio
30,510
Q2 2022 Added 28,957.14%
$27.5B
$1.03 Million 0.66% of portfolio
14,419
Q2 2022 Reduced 12.33%
$15.6B
$988,000 0.63% of portfolio
7,435
Q2 2022 Added 9.35%
$243B
$988,000 0.63% of portfolio
23,175
Q2 2022 Added 10.72%
$974M
$945,000 0.6% of portfolio
38,214
Q2 2022 Added 98.15%
$27.5B
$893,000 0.57% of portfolio
67,409
Q2 2022 Added 91.08%
$5.29B
$864,000 0.55% of portfolio
14,456
Q2 2022 Reduced 53.74%
$51.9B
$865,000 0.55% of portfolio
2,767
Q2 2022 Reduced 20.81%
$42.1B
$858,000 0.55% of portfolio
13,562
Q2 2022 Reduced 0.88%
$115B
$836,000 0.53% of portfolio
13,537
Q2 2022 Reduced 26.37%
$114B
$804,000 0.51% of portfolio
4,090
Q2 2022 Reduced 24.59%
$132B
$789,000 0.5% of portfolio
6,264
Q2 2022 Reduced 5.05%
$10.2B
$785,000 0.5% of portfolio
16,639
Q2 2022 Added 11.78%
$148B
$709,000 0.45% of portfolio
13,531
Q2 2022 Reduced 36.52%
$162B
$692,000 0.44% of portfolio
2,055
Q2 2022 Reduced 1.25%
$31.6B
$666,000 0.43% of portfolio
11,467
Q2 2022 Reduced 21.49%
$53.6B
$674,000 0.43% of portfolio
18,872
Q2 2022 Reduced 48.63%
$216B
$680,000 0.43% of portfolio
1,431
Q2 2022 Reduced 1.11%
$883M
$657,000 0.42% of portfolio
7,149
Q2 2022 Reduced 20.61%
$209B
$620,000 0.4% of portfolio
3,723
Q2 2022 Reduced 2.13%
$7.2B
$605,000 0.39% of portfolio
6,416
Q2 2022 Added 1,815.22%
$15.4B
$609,000 0.39% of portfolio
4,267
Q2 2022 Added 8.94%

Summary

  • Portfolio
  • No. of Stocks 758
  • Current Value $157 Million
  • Prior Value $323 Million
  • Filing
  • Period Q2 2022
  • Filing Date July 12, 2022
  • Form Type 13F-HR
  • Activity in Q2 2022
  • New Purchases 57 stocks
  • Additional Purchases 90 stocks
  • Sold out of 316 stocks
  • Reduced holdings in 353 stocks
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email